To this end, hiPSC-CMs were exposed to the iron chelator deferoxamine (DFO) for 4 days to simulate ID and we used transferrin for 2 days to rescue the iron deficiency phenotype given that transferrin supplementation is routinely used in iron replacement therapy. This evidence concerns the gene TF and nutritional disorder.